Financial Reports Latest Updates Industry Maps Economic Calendar

PRECISION BIOSCIENCES INC (DTIL) Annual Reports

Q: Where can I read PRECISION BIOSCIENCES INC (DTIL) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

PRECISION BIOSCIENCES INC is listed on Nasdaq, classified by the SEC under Biological Products, (No Diagnostic Substances) (SIC 2836). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 05/21
SEC CIK： 1357874 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$0	$18,000	-100.0%
Operating income	$-19.2M	$-21.9M	+12.4%
Net income	$-32.7M	$-23.5M	-38.8%
EPS (diluted)	$-1.26	$-2.13	+40.8%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 0 mn Net income -32.6 mn

Show table：Income statement

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	1.53	1.87	2.54	4.94	5.46	5.39	4.87	6.52	7.00	1.08	7.36	8.85	16.4	68.8	24.0	6.34	3.32	3.82	7.36	10.6	8.78	19.8	13.1	7.04	17.6	49.9	0.58	0.64	0.03	0.02	0.01	34.2	10.8	0
Operating income	-9.23	-12.1	-10.4	-16.1	-19.5	-23.9	-22.0	-21.9	-27.5	-32.8	-26.0	-23.5	-18.7	21.6	-11.5	-30.8	-27.4	-29.6	-22.9	-20.5	-24.5	-12.0	-12.4	-14.9	-4.19	24.1	-21.3	-24.9	-22.1	-21.9	-20.7	12.5	-9.07	-19.2
Net income	-9.01	-11.8	-9.76	-15.4	-31.8	-19.4	-20.7	-20.9	-26.8	-32.7	-26.0	-23.4	-18.7	21.7	-11.3	-22.3	-28.2	-31.0	-23.9	-28.5	-25.1	-11.9	-8.08	-16.3	8.59	32.8	-16.4	-17.7	-20.6	-23.5	-21.8	20.1	-18.4	-32.6

Balance sheet

Quarterly · In mn (USD)

Total assets 126 mn Total liabilities 80.6 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	116	137	237	220	194	167	137	123	106	219	188	183	162	134	248	225	199	169	148	146	136	161	144	111	95.0	82.1	70.3	51.7	119	109	91.5
Total assets	—	—	—	139	167	272	260	235	214	184	169	150	262	230	227	212	181	297	272	238	205	182	164	160	185	166	153	136	124	109	93.5	154	144	126
Current liabilities	—	—	—	14.1	71.4	15.8	23.7	26.9	23.8	34.3	42.0	42.8	63.8	36.3	36.5	36.0	29.1	53.9	61.1	59.7	46.9	56.4	50.6	50.0	33.3	33.0	12.0	15.0	12.4	13.6	15.0	8.91	7.76	7.14
Total liabilities	—	—	—	98.6	156	97.9	105	96.9	99.2	98.6	105	106	203	130	126	120	112	194	187	178	164	148	135	141	148	91.1	88.4	80.0	75.1	74.9	76.9	62.2	67.8	80.6
Equity	-35.2	41.1	53.6	40.0	10.8	174	156	138	115	85.6	63.8	44.4	58.8	101	101	91.2	69.7	103	84.4	60.4	40.2	34.0	29.1	18.9	37.2	74.7	64.9	56.4	49.3	34.0	16.6	92.3	76.1	45.3

Cash flow

Quarterly · In mn (USD)

Operating -13.4 mn Investing 0 mn Financing 0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-14.4	-9.31	-15.1	-12.9	-19.9	-16.6	-14.0	-20.6	-25.9	-25.8	-22.2	-13.4	68.1	-31.3	-23.9	-23.7	-28.9	-24.2	29.2	-21.8	-31.5	-21.1	-23.1	-8.42	-19.0	-14.9	-5.91	-18.7	-19.1	-20.3	-15.3	-11.3	-11.9	-13.4
Investing	-0.62	-1.13	-4.04	-9.87	-5.08	-8.14	-5.92	-5.53	-1.10	-1.78	-1.05	-1.10	-1.12	-1.69	-1.48	-1.50	-0.82	-0.78	-1.09	-0.63	-0.72	-1.06	7.56	0.04	-0.03	-0.03	-0.06	-0.1	-0.31	-0.01	0.02	-0.32	-0.11	0
Financing	0.02	88.0	21.3	-1.59	38.3	134	0.06	0.71	0.31	0.28	0.53	0.2	36.7	13.5	11.9	8.38	2.25	92.9	-0.18	0	0.74	1.85	-0.03	2.83	40.1	0.7	3.73	5.92	10.7	5.30	1.66	77.5	0.75	0
Cash at period end	47.8	125	128	103	117	226	206	181	154	127	104	89.8	193	174	160	144	116	184	212	190	158	138	122	117	138	124	98.8	85.9	77.2	62.2	44.9	111	99.4	86.1

Profitability

Quarterly · %

Operating margin -83.7% Net margin -170.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	-604.4%	-647.0%	-411.1%	-326.0%	-356.9%	-443.0%	-451.8%	-335.2%	-392.9%	-3043.4%	-353.7%	-265.4%	-114.6%	31.4%	-48.0%	-485.1%	-824.4%	-774.9%	-311.4%	-193.3%	-278.6%	-60.6%	-94.2%	-211.6%	-23.8%	48.4%	-3693.6%	-3894.4%	-76248.3%	-121538.9%	-158976.9%	36.6%	-83.7%	—
Net margin	-589.8%	-631.1%	-383.9%	-312.6%	-581.9%	-360.7%	-426.4%	-320.7%	-383.5%	-3033.5%	-353.3%	-265.1%	-114.3%	31.5%	-46.9%	-351.6%	-849.2%	-812.4%	-325.2%	-268.8%	-285.4%	-60.1%	-61.6%	-231.4%	48.8%	65.6%	-2851.6%	-2781.3%	-70913.8%	-130666.7%	-167476.9%	58.9%	-170.2%	—

Returns & leverage

Quarterly · %

ROE -132.9% ROA -44.9% Debt ratio 64.0%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-115.2%	—	-71.1%	-83.5%	-104.2%	-139.7%	-78.0%	-97.0%	-119.3%	-116.0%	-50.0%	-38.4%	-45.1%	-62.4%	-91.1%	-113.5%	-147.3%	-197.6%	-130.4%	-129.6%	-154.7%	-71.5%	31.2%	18.4%	19.1%	-50.8%	-143.9%	-205.2%	-61.5%	-69.5%	-132.9%
ROA	—	—	—	-33.2%	-41.3%	-28.1%	-33.6%	-49.7%	-46.2%	-44.4%	-49.6%	-56.6%	-42.3%	-22.4%	-16.1%	-16.9%	-18.1%	-35.2%	-42.3%	-49.6%	-56.3%	-37.3%	-33.7%	-30.8%	-14.2%	9.8%	5.4%	4.8%	-14.2%	-57.0%	-67.8%	-31.4%	-32.5%	-44.9%
Debt ratio	—	—	—	71.2%	93.5%	36.0%	40.1%	41.2%	46.3%	53.5%	62.2%	70.4%	77.6%	56.3%	55.4%	56.9%	61.6%	65.3%	69.0%	74.6%	80.3%	81.3%	82.3%	88.2%	79.9%	54.9%	57.7%	58.6%	60.3%	68.7%	82.2%	40.3%	47.1%	64.0%

EPS

Quarterly · US$

EPS US$-1.26

Show table：EPS

Item	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	-0.63	—	—	—	0.36	-0.19	-0.38	-0.46	-0.46	-0.22	-0.23	-0.23	-0.10	-0.07	-15.56	1.70	4.67	-2.25	-2.74	-2.21	-2.13	-1.84	2.58	-0.75	-1.26

Revenue & profit

Year-to-date · In mn (USD)

Revenue 10.8 mn Net income -51.1 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 126 mn Total liabilities 80.6 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -25.4 mn Investing -0.11 mn Financing 0.75 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -260.5% Net margin -471.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -132.9% ROA -44.9% Debt ratio 64.0%

EPS

Year-to-date · US$

EPS US$-2.01

Revenue & profit

Annual · In mn (USD)

Revenue 34.3 mn Net income -45.7 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	10.9	22.2	24.3	116	25.1	48.7	68.7	34.3
Operating income	-47.9	-87.2	-110	-39.4	-100	-63.7	-26.2	-52.1
Net income	-46.0	-92.9	-109	-30.6	-112	-61.3	7.17	-45.7

Balance sheet

Annual · In mn (USD)

Total assets 154 mn Total liabilities 62.2 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	116	194	106	162	199	136	95.0	119
Total assets	139	235	150	212	238	160	136	154
Current liabilities	14.1	26.9	42.8	36.0	59.7	50.0	15.0	8.91
Total liabilities	98.6	96.9	106	120	178	141	80.0	62.2
Equity	40.0	138	44.4	91.2	60.4	18.9	56.4	92.3

Cash flow

Annual · In mn (USD)

Operating -65.8 mn Investing -0.63 mn Financing 95.2 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-51.7	-71.0	-87.4	-10.8	-45.8	-84.1	-58.4	-65.8
Investing	-15.7	-24.7	-5.03	-5.80	-3.32	5.83	-0.21	-0.63
Financing	108	173	1.33	70.5	95.0	5.39	50.5	95.2
Cash at period end	103	181	89.8	144	190	117	85.9	111

Profitability

Annual · %

Operating margin -152.2% Net margin -133.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	-440.3%	-392.1%	-452.3%	-34.1%	-399.9%	-130.7%	-38.1%	-152.2%
Net margin	-423.0%	-417.6%	-448.9%	-26.5%	-444.8%	-125.8%	10.4%	-133.4%

Returns & leverage

Annual · %

ROE -61.5% ROA -31.4% Debt ratio 40.3%

Show table：Returns & leverage

Item	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-115.2%	-104.2%	-119.3%	-45.1%	-147.3%	-154.7%	19.1%	-61.5%
ROA	-33.2%	-49.7%	-56.6%	-16.9%	-49.6%	-30.8%	4.8%	-31.4%
Debt ratio	71.2%	41.2%	70.4%	56.9%	74.6%	88.2%	58.6%	40.3%

EPS

Annual · US$

EPS US$-3.60

Show table：EPS

Item	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	-1.37	-15.96	1.38	-3.60

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read PRECISION BIOSCIENCES INC (DTIL) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.